ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 176 filers reported holding ZAI LAB LTD in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,429,000 | +64.6% | 156,554 | +108.7% | 1.12% | +30.2% |
| Q1 2022 | $3,299,000 | -25.4% | 75,000 | +200.0% | 0.86% | -29.6% |
| Q2 2021 | $4,425,000 | -26.3% | 25,000 | -44.4% | 1.22% | -29.0% |
| Q1 2021 | $6,004,000 | +47.9% | 45,000 | +50.0% | 1.72% | +42.0% |
| Q4 2020 | $4,060,000 | +95.3% | 30,000 | +20.0% | 1.21% | +89.9% |
| Q3 2020 | $2,079,000 | – | 25,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 304,820 | $10,154 | 23.52% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $15,299,600 | 11.92% |
| Genesis Investment Management, LLP | 1,569,764 | $52,210 | 5.67% |
| Privium Fund Management B.V. | 240,683 | $8,005,117 | 2.69% |
| Segantii Capital Management Ltd | 2,278,275 | $75,775,427 | 2.66% |
| Paradigm Biocapital Advisors LP | 780,558 | $25,961,359 | 2.46% |
| HSG Holding Ltd | 694,634 | $23,103,527 | 2.43% |
| E Fund Management (Hong Kong) Co., Ltd. | 82,587 | $2,747 | 1.53% |
| INDUS CAPITAL PARTNERS, LLC | 25,256 | $840,015 | 1.29% |
| Vivo Capital, LLC | 416,640 | $13,857,446 | 0.96% |